TEMPE, Ariz.--(BUSINESS WIRE)-- Amkor Technology, Inc. (Nasdaq: AMKR), a leading provider of semiconductor packaging and test services, today announced financial results for the fourth quarter and full year ended December 31, 2025.
Fourth Quarter 2025 Highlights:
- Fourth quarter net sales $1.89 billion, up 16% year-on-year
- Net income $172 million, earnings per diluted share $0.69
Full Year 2025 Highlights:
- Net sales $6.71 billion, up 6%... (continue reading...)
Fourth-Quarter 2025 Highlights
- Orders of $803.4 million, up 55.8% year-over-year
- Net sales of $677.1 million, up 13.6% year-over-year
- Non-new machine sales of $190.9 million, up 14.0% year-over-year
- Net cash provided by operating activities of $91.1 million, free cash flow of $78.3 million
Full-Year 2025 Highlights
- Net sales of $2,240.9 million, up 2.9% year-over-year
- Non-new machine sales of $690.5 million, up 9.8% year-over-year
- Backlog of... (continue reading...)
Revenue increased 24% resulting in record revenue, gross profit, and operating profit, surpassed $425M in revenues for the twelve months ended December 31, 2025, and continued investments in modernization and optimization initiatives.
MIAMI--(BUSINESS WIRE)-- EVI Industries, Inc. (NYSE American: EVI) announced today its operating results for the second quarter of the fiscal year ending June 30, 2026. The Company also provided updates related to its buy-and-build... (continue reading...)
- Conducting Phase 3 Enabling Activities, Including Discussions with U.S. Food & Drug Administration (FDA), for Zelicapavir, an N-Protein Inhibitor in Development to Treat Respiratory Syncytial Virus (RSV)
- Introduced New Immunology Program Focused on MRGPRX2 Inhibition; On Track to Select a Development Candidate in 2H 2026
- On Track to File an Investigational New Drug Application (IND) in 1Q 2026 and Report Phase 1 Data in 4Q 2026 for EDP-978, an Oral, Once-Daily... (continue reading...)
DALLAS--(BUSINESS WIRE)-- Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company focused on autoimmune and autoimmune-related diseases, today announced it will be presenting at two upcoming investor meetings.
Forte’s CEO, Paul Wagner, PhD will be presenting at the Guggenheim Emerging Outlook: Biotech Summit at 8:30 am ET on February 11th hosted at the Lotte New York Palace in New York, NY.
Additionally, on March... (continue reading...)
More Business Wire
View Older Stories-
Xsolla to Showcase New Brand With All the Things for Developers to Go Direct-to-Consumer at DICE Summit 2026, Empowering Developers to Launch, Grow, and Win
-
Primaris REIT Announces Distribution for February 2026
-
Red Pine Announces Effective Date of Name Change to RPX Gold Inc.
-
TD Launches New Brand Platform "More Human," Reflecting A Digital-First, People-Centered Future
-
Grant Thornton earns perfect score in Human Rights Campaign Foundation’s 2026 Corporate Equality Index
-
TRENDS Unifies 50+ Systems to Build AI-Ready Manufacturing Backbone
-
KBRA Assigns AA- Rating to Lee County, FL Airport Revenue Bonds Series 2026; Affirms Outstanding Bonds at AA-; Outlook is Stable
-
Paula Autry Joins Alder Bowman as Market Executive Director, Healthcare Consulting
-
martinwolf Advises Fiducius on its Acquisition by Savi
-
Arrow Electronics Launches Initiative to Support Next-Generation Vehicle E/E Architecture
-
Mercialys: Number of Outstanding Shares and Voting Rights as of January 31, 2026
-
Xsolla Brings Mobile-First Monetization Expertise to Gamesforum Barcelona 2026, Where Europe's Mobile Gaming Leaders Gather to Solve the Industry's Toughest Growth Challenges
-
Telgoo5 and Prosurety Announce Exclusive Strategic Integration to Redefine the MVNO Ecosystem
-
KBRA Assigns Preliminary Ratings to Castlelake Aircraft Structured Trust 2026-1
-
StubHub Appoints Jill Gonzalez as Head of Consumer, Product & Tech Communications
-
Washington Court of Appeals Denies State's Action to Overturn Jury Verdict In Sexual Assault Case, According to Dearie Law Group
-
Wolters Kluwer CCH® Tagetik Intelligent Platform with Expert AI Named a Leader in 2026 Nucleus Research CPM Technology Value Matrix for the Sixth Consecutive Year
-
Teledyne Advances U.S. National Defense with Multiple Awards for SDA’s Tranche 3 Tracking Layer Program
-
Kautex Textron Achieves CDP Climate Change Leadership Status and Improves Water Security Stewardship Score
-
Xsolla Supports Release of “State of the African Video Game Industry 2026” Report
-
WabashTM Unveils Next-Generation Cargo Assurance Solution at Manifest 2026
-
Airspan Networks Enters 2026 with Strong Growth and Profitability
-
Hillsdale College Announces ‘Learn Like Charlie’ Campaign During TPUSA’s All-American Halftime Show
-
KDC Expands Data Center Development Platform, Welcomes Industry Veteran Robert Child as Executive Vice President
-
Capstone Accounting and Tax Partners with Peltier, Gustafson & Miller in New Mexico to Expand Presence into Albuquerque Market
-
Transfix and GenLogs Partner to Bring Real-Time Freight Intelligence Directly into the Transfix TMS Experience
-
Fervo Energy Drills Deepest and Hottest Well to Date at New Giga-Scale Geothermal Project Site
-
Agenus to Present New Data at AACR-IO Exploring Systemic and Tumor Inflammation Biomarkers with BOT/BAL in Immunologically Cold Tumors
-
Miller Expands Its Battery Powered Lineup with the Venture™ 150 T
-
Schwab Trading Activity Index™: STAX Score Sees Highest Reading Since February 2025
-
Symetra Launches New Chapter of ‘Plan Well, Play Well’ Campaign With Sue Bird
-
Beast Industries Acquires Step, Expanding its Platform to Include Financial Services
-
Reltio Achieves AWS Financial Services Competency
-
Association for Consumer Debt Relief Welcomes Robert Swanger as Head of Public Affairs
-
Danube Properties Launches ‘Serenz by Danube’ in JVC With A Convenient 2-Minutes-In, 2-Minutes-Out Access
-
Elavon launches fresh logo and bold new look for a dynamic 2026
-
Modveon Raises $10 Million to Build a Verified Operating System for Governments and Citizens
-
KBRA Assigns Preliminary Ratings to MAST 2026-1 Limited and MAST 2026-1 LLC
-
CyberCube Announces CEO Succession as Part of Next Phase of Growth
-
MD7 and Tikehau Star Infra Announce $100M Strategic Equity Partnership to Strengthen Long-Term Telecom Infrastructure Stability
-
Dispatch Science Unveils Unified Logistics Platform at Manifest 2026
-
Maas Energy Works Commissions Renewable Natural Gas (RNG) Interconnection in Collaboration with Pacific Gas and Electric Company
-
Google and Entrust Announce Partnership to Advance AI-Powered Identity Verification, Fraud Monitoring, and Analytics
-
Streamline Healthcare Solutions Appoints Danny Gladden, MBA, MSW, LCSW, as Chief Clinical Officer
-
Comcast Completes Network Expansions to Residents and Businesses in Spokane County
-
NineDot Energy Completes $431 Million Financing With Natixis Corporate & Investment Banking For 28 Battery Energy Storage Projects In New York City
-
Eurofins Scientific SE: Weekly Report on Share Repurchases from 02nd February to 06th February 2026
-
Eurofins Scientific SE: Weekly Report on Share Repurchases from 02nd February to 06th February 2026
-
Dexory Boosts Warehouse Intelligence with Next-Generation Autonomous Robot and Storage Health Software Feature
-
Elevate Communications Strengthens Leadership, Diversifies Services With Strategic Hires and Promotions

